apr
Inauguration of Lund's new ATMP infrastructures
Welcome to the inauguration of Lund's new ATMP infrastructures on April 9!
Welcome to a full day about the ATMP infrastructures available in Lund!
The event is fully booked but you may still sign-up to attend the event online:
Program "Advancing science and innovation for cell and gene therapies"
08:30 Breakfast & mingle
09:00 Welcome
Lisa Kirsebom, science journalist and moderator
09:05 Keynote
Frank Staal, Professor of Stem Cell Biology, Leiden University Medical Center
09:45 Dawn: Pioneering beginnings
”REPLACING DOPAMINE NEURONS IN PARKINSON’S PATIENTS: THE PIONEERING YEARS” Olle Lindvall, Senior Professor of Neurology, Lund University Anders Björklund, Senior Professor of Neurobiology, Lund University
”STEM-PD - hESC DERIVED DOPAMINERGIC NEURON PROGENITORS FOR PARKINSON’S DISEASE” Malin Parmar, Professor of Cellular Neuroscience and Director, Lund Stem Cell Center, Lund University
PANEL DISCUSSION Malin Parmar, Olle Lindvall, and Anders Björklund moderated by Lisa Kirsebom
”WHY ATMPs IN LUND AND SKÅNE?” Stefan Jovinge, President of Research, Education, Development, and Innovation, Skåne University Hospital
10:25 Ribbon cutting
Erik Renström, Vice-Chancellor, Lund University and Carl Johan Sonesson (M), Chair, Regional Executive Board in Skåne
10:40 Fika break
11:10 Present: Current clinical applications
”GENE THERAPY IN METACHROMATIC LEUKODYSTROPHY – THE NORDIC TREATMENT CENTER IN LUND” Erik Eklund, Head of the Section of Pediatric Neurology, Pulmonology and Metabolism, Skåne Children's Hospital
”FACILITATING CLINICAL TRIALS WITH ATMPS” Ana Carneiro, Senior Consultant, Oncology, Skåne University Hospital
”IN VIVO GENE THERAPY FOR HEREDITARY FRONTAL LOBE DEMENTIA” Hjálmar Bjartmarz, Neurosurgeon, Skåne University Hospital
PANEL DISCUSSION – Erik Eklund, Ana Carneiro, and Hjálmar Bjartmarz moderated by Lisa Kirsebom
11:55 Lunch
12:55 On the Horizon
”HACKING CANCER CELLS TO BECOME GOOD: A SCIENCE COMMUNICATOR’S GUIDE TO CELLULAR REPROGRAMMING” Luís Oliveira, Doctoral Student, Lund University
”FROM SCIENCE TO START UP: DEVELOPING A GENE THERAPY FOR A RARE BLOOD DISORDER”
Johan Flygare, Associate Professor, Lund University
”DEVELOPING A PLURIPOTENT-DERIVED CELL THERAPY FOR CHOLINERGIC DEMENTIAS”
Agnete Kirkeby, Associate Professor, Lund University
”DEVELOPMENT OF HYPER-FUNCTIONAL IPS CELL DERIVED NK CELLS FOR ADOPTIVE CELL IMMUNOTHERAPY”
Niels-Bjarne Woods, Associate Professor, Lund University
13:35 Fika break
14:25 Research today, therapy tomorrow: How do we get there?
”ATMP MODEL BY LUND”
Anna Falk, Professor of Neural Stem Cells and Director, LU-ATMP, Lund University
”PRE-GMP FACILITY”
Elias Uhlin, Director, Pre-GMP-Facility, Lund University
”ATMP CENTER”
Gisela Helenius, Director, ATMP Center, Skåne University Hospital
”iACTORS”
Ulrika Ringdahl, CEO, SmiLe Venture Hub
PANEL DISCUSSION
Anna Falk, Elias Uhlin, Gisela Helenius, and Ulrika Ringdahl moderated by Lisa Kirsebom
14:55 Fika break
15:25 Industry, innovation and insights
XINTELA
Evy Lundgren-Åkerlund, CEO, Xintela AB
ASGARD THERAPEUTICS
Cristiana Pires, CEO, Asgard Therapeutics
NOVO NORDISK FOUNDATION CELLERATOR
Thomas H.R. Carlsen, CEO, Novo Nordisk Foundation Cellerator
ERLY THERAPEUTICS
Alex Evilevitch, Professor of Virus Biophysics, Lund University
PANEL DISCUSSION
Evy Lundgren-Åkerlund, Cristiana Pires, and Thomas H.R. Carlsen
16:40 Summary and reflections
Sarah Lidé, Deputy CEO, Medicon Village Innovation
16:45 – 19:00 Mingle
Om evenemanget
Plats:
Auditorium, Medicon Village, Scheelevägen 4, Lund
Kontakt:
press [at] med [dot] lu [dot] se